Novartis received European Medicines Agency (EMA) PRIME designation for iptacopan (LNP) in C3 glomerulopathy (C3G)

# # # Novartis Media Relations E-mail:?media.relations@novartis.com
Anja von Treskow Novartis Global Media Relations +41 61 324 2279 (direct) +41 79 392 8697 (mobile)?anja.von_treskow@novartis.com Eric Althoff Novartis US External Communications +1 646 438 4335 eric.althoff@novartis.com | Phil McNamara Novartis Cardio-Metabolic Communications +1 862 778 0218 (direct) +1 862 274 5255 (mobile)?philip.mcnamara@novartis.com |
Central | North America | ||
Samir Shah | +41 61 324 7944 | Sloan Simpson | +1 862 778 5052 |
Thomas Hungerbuehler Isabella Zinck | +41 61 324 8425 +41 61 324 7188 |